Robin Filmer-Wilson (British, born in 1975) was appointed director of the Company on June 10th, 2016. His term of office expires in the year 2022. Mr. Robin Filmer-Wilson is a founding shareholder of LABCO SAS, Europe’s largest diagnostic group, which he developed from EUR 25m in turnover to EUR 650m in turnover between 2004 to 2015, when the group was eventually sold to Cinven.
Robin is an experienced private equity professional with a global career beginning in 1998 at Brown Brothers Harriman in New York followed by Baring Private Equity, TCR Capital and most recently, ArchiMed SAS, Europe’s leading independent healthcare private equity group where he is a Managing Partner. He is also a Non-Executive Director of Hera Capital, a SE Asian private equity group and a Director of Menalabs Cerba, a Middle Eastern diagnostic group. Robin holds a BSFS from Georgetown University and an MBA from INSEAD.